The cutting edge. Severe hidradenitis suppurativa treated with adalimumab.
Moul
Danielle K
DK
University Hospitals of Cleveland and Case Western Reserve University, 11100 Euclid Avenue, Cleveland, OH 44106, USA.
Korman
Neil J
NJ
D000068879:Adalimumab; D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001365:Axilla / Q000473:pathology; D003937:Diagnosis, Differential; D004431:Ear, External / Q000473:pathology; D006119:Groin / Q000473:pathology; D017497:Hidradenitis Suppurativa / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000150:complications*; D007279:Injections, Subcutaneous; D008297:Male
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068879:Adalimumab